CLINICAL_TRIALS
trial_result
· 2023-08-08
Clinical Trial Update: Efficacy and Safety of Ustekinumab in Bullous Pemphigoid [Phase 2]
Summary
Phase 2 trial assessing efficacy and safety of ustekinumab in bullous pemphigoid has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CHU de Reims | Conditions: Bullous Pemphigoid | Phase 2 | Status: COMPLETED